Aleniglipron GLP-1 Pill Shows 12.1% Weight Loss in 36 Weeks
A new once-daily oral GLP-1 drug is adding momentum to the rapidly changing obesity-treatment market. In a Phase 2b trial…
A new once-daily oral GLP-1 drug is adding momentum to the rapidly changing obesity-treatment market. In a Phase 2b trial…
McAllen, Texas, in the Rio Grande Valley, has become a striking example of how obesity can be influenced by much…
GLP-1 drugs have become a major part of modern treatment for type 2 diabetes and obesity. These medicines mimic the…
GLP-1 drugs have become some of the most closely watched medicines in diabetes and obesity treatment. These medicines mimic the…
The obesity-drug market has entered a new phase in 2026: GLP-1 weight-loss medicines are moving from weekly injections to daily…
As obesity continues to rise globally, 2026 is shaping up to be a landmark year for new medical weight loss…
Novo Nordisk has officially launched the first-ever GLP-1 pill for obesity in the United States—and for once, the headline isn’t…